SCHEMBL4422235

SCHEMBL4422235

COc1cc2c(c(OC)c1)C(c1cc(Cl)cc(Cl)c1)N(S(=O)(=O)c1cc(Cl)ccc1OC)CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.48
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.41
TSHR P16473 2/20 0.41
HTT P42858 1/20 0.41
CPT1A P50416 1/20 0.41
CPT1B Q92523 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4414625 0.91 CA1 (0.45) KDM4EALDH1A1POLBHPGDRAB9A
SCHEMBL4423028 0.84 CA1 (0.41) KDM4EALDH1A1POLBHPGDRAB9A
SCHEMBL13973317 0.84 CA1 (0.41) KDM4EALDH1A1POLBHPGDRAB9A
SCHEMBL13972868 0.83 CA1 (0.41) CA1CA2CA9CA14LMNA
SCHEMBL4412933 0.83 CA1 (0.41) CA1CA2CA9CA14LMNA
SCHEMBL4412007 0.82 MAPT (0.46) CA1CA2CA9CA14TP53
SCHEMBL4414908 0.82 PKM (0.48) ALDH1A1RAB9ACA1CA2CA9
SCHEMBL4412965 0.80 HCRTR1 (0.44) ALDH1A1CA1CA2CA9CA14
SCHEMBL13972641 0.80 GAA (0.40) CA1CA2CA9CA14KMT2A
SCHEMBL4416959 0.80 GAA (0.40) CA1CA2CA9CA14KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663983-B1 N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2009-01-21 EP disclosed
EP-1663983-A1 N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2006-06-07 EP disclosed
US-20050070570-A1 Novel potassium channels modulators 4SC AG (DE) 2005-03-31 US disclosed
WO-2004113302-A1 N-SUBSTITUTED 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2004-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070570-A1 Novel potassium channels modulators HCN4, KCNA4, KCNN4 KDM4E 811/4885ALDH1A1 3171/4885POLB 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.